Skip to content
lifestyle.marketresearchjournals.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Spago Nanomedical
The Subscription Period in Spago Nanomedical’s Rights Issue Begins Today
June 3, 2026
Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 16 Million
May 26, 2026
Spago Nanomedical Publishes the Annual Report for 2025
May 25, 2026
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
May 25, 2026
Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)
May 24, 2026
Spago Nanomedical Interim Report January-March 2026
May 23, 2026
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 23, 2026
Spago Nanomedical Continues Recruitment in The Phase I/IIa Tumorad-01 Study Following Positive DMC Recommendation
March 17, 2026
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
Spago Nanomedical Year-End Report January-December, 2025
February 11, 2026
1
2
Next Page
→